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Targeted metabolomic profiling in 
rat tissues reveals sex differences
Margherita Ruoppolo1,2,3, Marianna Caterino1,2,3, Lucia Albano1,2, Rita Pecce1, Maria Grazia Di 
Girolamo1,2, Daniela Crisci1,2, Michele Costanzo1, Luigi Milella4, Flavia Franconi5,6 &  
Ilaria Campesi  5
Sex differences affect several diseases and are organ-and parameter-specific. In humans and animals, 
sex differences also influence the metabolism and homeostasis of amino acids and fatty acids, which 
are linked to the onset of diseases. Thus, the use of targeted metabolite profiles in tissues represents 
a powerful approach to examine the intermediary metabolism and evidence for any sex differences. 
To clarify the sex-specific activities of liver, heart and kidney tissues, we used targeted metabolomics, 
linear discriminant analysis (LDA), principal component analysis (PCA), cluster analysis and linear 
correlation models to evaluate sex and organ-specific differences in amino acids, free carnitine and 
acylcarnitine levels in male and female Sprague-Dawley rats. Several intra-sex differences affect 
tissues, indicating that metabolite profiles in rat hearts, livers and kidneys are organ-dependent. Amino 
acids and carnitine levels in rat hearts, livers and kidneys are affected by sex: male and female hearts 
show the greatest sexual dimorphism, both qualitatively and quantitatively. Finally, multivariate 
analysis confirmed the influence of sex on the metabolomics profiling. Our data demonstrate that 
the metabolomics approach together with a multivariate approach can capture the dynamics of 
physiological and pathological states, which are essential for explaining the basis of the sex differences 
observed in physiological and pathological conditions.
Numerous sex differences in the epidemiology, prevention, natural history, therapy and outcomes of diseases 
have recently been recognized1,2. Cardiovascular diseases, diabetes mellitus, renal and liver diseases are strongly 
influenced by sex1–3. Furthermore, sex differences in metabolic pathways, including lipid metabolism, have been 
reported4,5. Many sex differences appear to be organ- and parameter-specific6–8 and, therefore, they have to be 
identified as single parameters in individual organs. Rats with mice are the most used animals in preclinical 
pharmacological and toxicological tests9. Therefore, it is relevant to know if sex differences exist in rats and if such 
differences can be translate into humans.
The exact influence of sex on carnitine and its acyl esters (acylcarnitines, ACs) is not known, although some 
sex differences have been described, as in the case of free carnitine (C0) in plasma, liver, heart and skeletal muscle 
of pre-weaning rats10. In addition, C0, hexanoylcarnitine (C6), dodecanoylcarnitine (C12), tetradecanoylcar-
nitine (C14), hexadecanoylcarnitine (C16), octadecanoylcarnitine (C18), octadecenoylcarnitine (C18:1), and 
octadecadienoylcarnitine (C18:2) are lower in the male than in the female heart11, while octanoylcarnitine (C8), 
hexadecenoylcarnitine (C16:1), octadecatrienoylcarnitine (C18:3), and some long chain acylcarnitines (>C20) 
have similar levels in both sexes in Wistar rats11.
Carnitine and ACs are essential for the metabolism of fatty acids because they are vital for the transport 
of fatty acids across the mitochondrial membrane for beta oxidation, which produces acetyl-Coenzyme A and 
chain-shortened acyl products to preserve cellular coenzyme A (CoA) homeostasis12,13. ACs are very relevant in 
tissues characterized by high rates of beta oxidation, such as cardiac muscle, in which approximately 70–80% of 
the energy requirements are derived from fatty acid oxidation14.
Notably, C0 and ACs are dependent upon amino acids. In particular, endogenous carnitine synthesis, which 
mainly occurs in the liver and kidneys, requires the methylation of lysine (Lys) and methionine (Met) residues15. 
Propionylcarnitine (C3), isovalerylcarnitine (C5), and methylmalonyl carnitine (C4DC) are derived from the 
branched-chain amino acids isoleucine (Ile) and leucine (Leu)16, and together with the aromatic amino acids 
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tyrosine (Tyr) and phenylalanine (Phe), these compounds are significantly associated with the prevalence and 
incidence of diabetes mellitus16. However, other intermediates can produce ACs7,16, whereas other tissues, such as 
skeletal muscle and heart acquire C0 from the blood15,17.
Considering that sex differences influence pathophysiology, disease outcomes, therapy, drug discovery and 
development, including preclinical tests, which very often utilize rats18,19, it is important to know whether sex 
affects the profile of carnitine and ACs in the liver, heart and kidneys of rats in order to have a powerful approach 
in examining intermediary metabolism. To gain a deeper insight into the sex-specific activities of the liver, heart 
and kidney, we use a targeted MS-based metabolomic platform to measure 13 amino acids and 37 ACs in healthy 
male and female rats while lysine (Lys), a precursor of carnitine16, was measured by HPLC. Target metabolomic 
profiling is one of the scientific approach to characterize biological systems, which ensure versatility, speed and 
reproducibility especially in quantitative analysis, allowing the analysis of a large number of samples. The data 
were collected at the same time and from the same animals and was integrated with several multivariate methods 
(cluster analysis, principal component analysis (PCA), linear discriminant analysis (LDA)) and linear correlation 
models to assess the correlations among the analysed molecules to ameliorate our knowledge on sex differences.
Results
Weights of animals and protein contents. The male and female rats enrolled were age-matched (7 
weeks). As expected, females showed a significantly lower body weight than males (227 ± 13 g for males and 
195 ± 10 g for females; P < 0.001). We chose age-matched animals with different body weights because age exerted 
important effect on metabolomics20,21. The total protein content was measured in each samples (15 for each sex 
and for each organ), and no statistical significant sex differences were detected. The protein abundance was 
6.30 ± 2.27 and 6.53 ± 2.48 mg/ml for male and female livers, respectively; 11.90 ± 3.90 and 14.10 ± 2.90 mg/ml 
for male and female hearts, respectively; and 12.59 ± 0.91 and 17.52 ± 9.33 mg/ml for male and female kidneys, 
respectively. Metabolomic data were normalized to the total tissue protein content.
Intra-sex and inter-organ analysis of amino acids. In male cardiac ventricles, the concentrations of 
alanine (Ala), valine (Val), Leu + Ile (Xle), Met, Phe, Tyr, aspartate (Asp), glutamate (Glu), glycine (Gly), orni-
thine (Orn), and Lys were significantly lower than in the two other tissues (Fig. 1A). Conversely, the renal levels 
of arginine (Arg) and argininosuccinate (ArgSuc) were significantly higher than those in the liver and heart 
(Fig. 1B). The renal Orn concentration was significantly lower than that of the liver. Finally, the citrulline (Cit) 
abundance did not differ among the analysed tissues (Fig. 1B).
Figure 1. Intra-sex analysis of amino acids in livers (black bars), hearts (white bars) and kidneys (grey bars) 
of male (M) and female (F) rats. Data are the medians ± MAD of 15 samples for each tissue and sex. aP < 0.05 
between liver and heart; bP < 0.05 between kidney and liver; cP < 0.05 between heart and kidney.
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In female rats, overall, the cardiac amino acids levels were significantly lower than in the two other female tis-
sues (Fig. 1C). Cardiac and hepatic Cit and Arg did not differ in a statistically significant manner, but Cit showed 
a significant intra-sex difference between the heart and kidney. Arg was significantly higher in kidneys than in 
livers and hearts, and Orn was significantly higher in livers than in kidneys (Fig. 1D).
Inter-sex analysis of amino acids. Livers did not display significant sex differences in amino acids con-
tent (data not shown). In renal tissue, only ArgSuc showed a significant difference between males and females 
(1.95 ± 1.01 and 0.68 ± 0.36 nmol/mg proteins for males and females, respectively; P = 0.025, N = 15 for each 
experimental group). Moreover, in cardiac ventricles Glu, Gly, Ala, Xle, Val, Phe, Orn, Cit and Lys were signifi-
cantly higher in male hearts than in female ones (Fig. 2A). By contrast, Asp, Arg, Tyr, Met, and ArgSuc did not 
display any significant sex differences (Fig. 2A).
Intra-sex and inter-organ analysis of ACs. In males, C0 and total esterified carnitines (TE) were sig-
nificantly lower in the heart than in the liver, whereas the TE/C0 ratio was significantly higher in livers than in 
the two other tissues (Fig. 3). In male rats, the intra-sex analysis of ACs revealed that among saturated carni-
tines, acetylcarnitine (C2) and C5 were significantly lower in the heart, whereas the concentrations of C3, buty-
rylcarnitine/isobutyrylcarnitine (C4), the fatty acid derived C6 and octanoylcarnitine (C8), decanoylcarnitine 
(C10), C12, C14, C16, C18, malonylcarnitine (C3DC), C4DC, glutarylcarnitine (C5DC), methylglutarylcarnitine 
(C6DC), octanedioylcarnitine (C8DC), and decanedioylcarnitine (C10DC) were significantly higher in the livers 
than in the two other tissues (Fig. 4A,B). The concentrations of the unsaturated carnitines tiglylcarnitine (C5:1), 
hexenoylcarnitine (C6:1), octenoylcarnitine (C8:1), decenoylcarnitine (C10:1), dodecenoylcarnitine (C12:1), 
tetradecenoylcarnitine (C14:1), C16:1, C18:1, decadienoylcarnitine (C10:2), tetradecadienoylcarnitine (C14:2), 
and C18:2 were significantly higher in the livers than in the 2 other tissues (Fig. 4C). The hydroxylated carni-
tines 3-hydroxybutyrylcarnitine (C4OH) which derived from ketone bodies22, 3-hydroxydodecanoylcarnitine 
(C12OH), 3-hydroxytetradecanoylcarnitine (C14OH), 3-hydroxyoctadecenoylcarnitine (C18:1OH), 
and 3-hydroxyoctadecenoylcarnitine (C18:1OH) (Fig. 4D), 3-hydroxyisovalerylcarnitine/3-hydroxy-2- 
methylbutyrylcarnitine (C5OH), 3-hydroxyhexanoylcarnitine (C6OH), and 3-hydroxyhexadecenoylcarnitine 
(C16:1OH) had significantly lower values in male hearts than in livers and kidneys (Fig.  4D); and 
3-hydroxyhexadecanoylcarnitine (C16OH) was significantly lower in the heart in comparison with the liver 
(Fig. 4D).
In female tissues, C0 was significantly lower in cardiac ventricles than in kidneys; the TE content had the 
lowest value in hearts in comparison with livers and kidneys, whereas the TE/C0 ratio was significantly higher in 
Figure 2. (A) Amino acids levels in male (black bars) and female (white bars) hearts. (B) C0, TE and TE/
C0 ratio in male (black bars) and female (white bars) hearts. Data are the medians ± MAD of 15 independent 
samples for each sex. *P < 0.05 and **P < 0.001, versus females. Percentage of variation in females is reported 
under amino acid names.
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livers than in the other two tissues (Fig. 3). In females, the levels of C2, C3, C4, C5:1, C5, C6, C5OH, C8, C10:1, 
C10, C5DC, C12:1, C12, C6DC, C14:2, C14:1, C14, C8DC, C16:1, C16, C10DC, C16OH, C18:1, C18, C18:1OH, 
C6OH, C6:1, C8:1, C10:2, C12OH, and C14OH were lower in female hearts than in livers and kidneys (Fig. 4E–H). 
C4DC had the lowest value in kidney compared to livers and hearts, whereas C12:1 was also significantly higher 
in livers than in kidneys, as was C4OH (Fig. 4F). These data demonstrated that males and females showed lower 
levels of carnitines in the heart.
Inter-sex analysis of carnitines and ACs. The level of C0, TE or in the TE/C0 ratio did not diverge 
between males and females in the liver and kidney (data not shown). In contrast, in cardiac ventricles, C0 and 
TE were significantly higher in males than in females, but the TE/C0 ratio did not present a sexual dimorphism 
(Fig. 2B).
At cardiac levels, C2, C6, C8, C10, C12, C6DC, C14:2, C14:1, C14, C8DC, C16, C10DC, C16OH, C18, 
C18:1OH, C6:1, C10:2, C12-OH, C14-OH, C16:1OH, and C18:2 were significantly higher in males than in 
females (Fig. 5A–F). The differences ranged from −10% to −57.1%. Only C3DC, C4DC, and C4OH were higher 
in female hearts than in male ones (Fig. 5C–E), but the sex differences were very large. In particular, C4DC, 
C4OH and C3DC were increased by approximately 1233%, 900%, and 150% respectively. C3, C4, C5, C5DC, 
C5:1, C8:1, C10:1, C12:1, C16:1, C18:1, C5OH, C6OH, and C18OH did not present significant sex differences 
(Fig. 5A–F).
Regarding renal levels, the majority of the saturated, unsaturated and hydroxylated carnitine (measured in 15 
animals of a single sex and expressed as nmol/mg protein) did not generally differ between males and females, 
with the exception of C3 (0.013 ± 0.006 and 0.07 ± 0.03 for males and females, respectively; P < 0.001), C4 
(0.008 ± 0.003 and 0.05 ± 0.03 for males and females, respectively; P < 0.001), C5 (0.01 ± 0.006 and 0.03 ± 0.01 for 
males and females, respectively; P = 0.022), C10 (0.004 ± 0.001 and 0.007 ± 0.03 for males and females, respec-
tively; P = 0.047), C5:1 (0.003 ± 0.00 and 0.005 ± 0.002 for males and females, respectively; P = 0.009), and C4OH 
(0.006 ± 0.002 and 0.02 ± 0.01 for males and females, respectively; P < 0.001), which were significantly higher in 
female kidneys than in male kidneys.
Correlation analysis between amino acids and carnitines. C0 is derived from Met and Lys23; there-
fore, we looked for the correlation between Met and Lys and C0. In all organs of both sexes, C0 and Met were 
significantly and positively correlated (Table 1). In contrast, Lys was not related to C0 levels in any organ of either 
sex (data not shown). Some carnitines such as C3, C5 and C4DC are derived from branched chain amino acids24; 
therefore, the association between them and Val and Xle was also evaluated. C3 was positively correlated with Val 
and Xle in male and in female livers and in the female hearts but not in kidneys (Table 1). In livers and hearts, Xle 
and Val were positively correlated with C5 in males and in females. In kidneys a significant positive correlation 
was detected only in females (Table 1). Finally, C4DC was positively correlated with Val and Xle in male and in 
female livers and kidneys and with Val and Xle only in female cardiac tissue (Table 1).
Cluster analysis. In all organs, 3 main clusters were evidenced (Fig. 6). In the liver, the branch A contained 
all male samples and 2 female samples, while the remaining samples were not clearly separable indicating the 
widest distance (and the higher variability) in comparison with the heart and kidney (Fig. 6A). At cardiac level, 
the cluster analysis confirmed the results of univariate analysis showing a clear sex discrimination. In particu-
lar, branch C contained all male samples (with the exception of 1 female sample) and had the widest distance 
from branches A and B (Fig. 6B). The latter contained the most of the females and 4 male samples. In kidney, 2 
sub-clusters in branch A (A1 and A2) divided samples per sex such as sub-branch 2B (Fig. 6C).
Figure 3. Intra-sex and inter-organ analysis of C0, TE and TE/C0 ratio in male and female livers (black bars), 
hearts (white bars) and kidneys (grey bars). Data are the medians ± MAD of 15 samples for each tissue and 
sex. aP < 0.05 between liver and heart; bP < 0.05 between kidney and liver; cP < 0.05 between heart and kidney. 
aP < 0.05 between liver and heart; bP < 0.05 between liver and kidney; cP < 0.05 between heart and kidney.
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LDA and PCA analysis. LDA and PCA were performed including all measured parameters. In LDA analy-
sis, organs and sexes were considered qualitative variables while tested compounds were considered quantitative 
variables. LDA analysis showed a clear organ clustering (Fig. 7A), while a significant separation between sexes 
was not evident. After stratification according to sex and organ, PCA revealed that the first (Comp 1) and second 
(Comp 2) principal components explained most of the variance in both sexes. In detail, in the male liver, Comp 
1 and Comp 2 explained 62% and 10% of the variance, respectively and a total of 25 components were gener-
ated. Amino acids demonstrated a low loading on Comp 2, with the exception of Lys, which was negatively and 
strongly related to Comp 2 (Figs 7B, S1A). In the female liver, Comp 1 and 2 explained 66% and 10% of the overall 
Figure 4. Intra-sex and inter-organ analysis of ACs in livers (black bars), hearts (white bars) and kidneys (grey 
bars) of male (M) and female (F) rats. Data are the medians ± MAD of 15 samples for each tissue and sex. 
aP < 0.05 between liver and heart; bP < 0.05 between liver and kidney; cP < 0.05 between heart and kidney.
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variance, respectively, and a lower number (21) of total components versus males were generated (Figs 7C, S1B). 
Comp 1 included all tested variables on the positive side, with Lys, TE/C0, C6 and C18:1OH showing the highest 
positive score. Xle, Glu, Gly, Arg, Met, Ala, Phe, Orn, Val, Tyr, C0 and C6 were negatively correlated with Comp 2, 
whereas ArgSuc and Lys were positively related to Comp 2. In male and female hearts, the variance was explained 
by 14 principal components (Figs 5D,E, S1C,D). In males, Comp 1 and Comp 2 explained 68% and 16% of the 
overall variance, respectively, and almost all amino acids (except Orn and Gly) were responsible for the positive 
variance of Comp 2. In female hearts, all variables were positively related to Comp 1, and all showed a strong 
loading, with the exception of Lys, C3 and TE/C0. Finally, in male and female kidneys, the variance was explained 
by 13 principal components a value that was very similar to that observed in the heart (Figs 7F,G, S1E,F). In detail, 
in male kidneys, Comp 1 and Comp 2 explained 56% and 18% of the variance, respectively. TE/C0, C3, C4, C5 
and C4OH showed a low loading on Comp 1, whereas all amino acids together with C0 were responsible for the 
negative variance of Comp 2. In females, numerous variables, except for C6:1, C8:1, ArgSuc and TE/C0, were 
positively related to Comp 1. Comp 2 mainly depended on amino acids that were all negatively correlated with it, 
with the exception of Lys.
Discussion
Here, using a target metabolomic approach, we confirm that some amino acids and AC levels are organ-dependent 
in the rat heart, liver and kidney. We also show that they clustered and are related to each other in an organ- and 
parameter-specific manner. However, the major novelty is represented by the effect of sex on the amino acids and 
AC levels.
Globally, the male and female livers contain the highest amount of C0, ACs and amino acids, with some excep-
tions, while, male and female hearts contain the lowest levels of the studied parameters, with some exceptions. 
Lower cardiac levels of amino acids could be ascribed, at least in part, to the high energy demand necessary for 
the activity of heart25. The fact that the highest levels of Orn occur in the liver is not surprising because Orn plays 
a crucial role in ammonia detoxification, which occurs mainly in the liver26, whereas the highest renal level of Arg 
could be ascribed to the so-called “intestinal-renal axis”27.
The levels of C0 and TE are similar in livers and kidneys, the organs involved in the biosynthesis and elimi-
nation of carnitine15. The low level of cardiac ACs could depend on the fact that the energy requirements of the 
heart are mainly derived from fatty acid oxidation14. The high levels of cardiac mitochondrial carnitine acet-
yltransferase could influence the mitochondrial acetyl-CoA balance, converting short-chain acyl-CoA into its 
corresponding carnitine conjugates and permitting the efflux of excess acyl moieties. Indeed, the notion that 
mitochondria could behave differently in different organs is not new. In particular, cardiac acetyl-CoA seems to 
be less accessible to carnitine acetyltransferase, as acetyl-CoA is more tightly coupled to the tricarboxylic acid 
cycle than it is in the liver or kidney14. The organ differences observed in C0 and ACs suggest that mitochondrial 
function is organ-specific, as supported by proteomics studies28. Organ-specific differences in the metabolome 
have been already described in the brain, heart, kidney, and liver tissues of 26 mammalian species29,30.
Figure 5. Inter-sex analysis of AC levels (nmol/mg protein) in male (M) and female (F) rat hearts. Values are 
the medians ± MAD of 15 independent samples for each sex. *P < 0.05 versus females.
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Interestingly, females display higher renal levels of C3, C4, C5, C10, C5:1, and C4OH, whereas cardiac C3DC, 
C4DC and C4OH are much more elevated in females than in males. C3DC, derived from malonyl-CoA, is a key 
regulator of fatty acid oxidation and an inhibitor of carnitine palmitoyltransferase 131, the rate-limiting enzyme 
for mitochondrial fatty acid uptake, and its inhibition leads to the reduction of fatty acid β-oxidation. C4DC is 
dependent on vitamin B1232, and the metabolism of methylmalonyl-CoA is inhibited in B12-deficient rats33,34. 
Finally, the dramatic increase in cardiac and renal C4OH suggests an impaired oxidation of hydroxybutyryl-CoA, 
an intermediate in ketone oxidation and a product of fatty acid oxidation. Furthermore, it has recently been 
suggested that C4OH could play a role in determining insulin resistance16, and interestingly, cardiac diabetic 
complications are more relevant in women than in men3,35. C3, C5, and C4DC are derived from branched chain 
amino acids Ile and Leu16, which, together with aromatic amino acids (Tyr and Phe), display a correlation with the 
onset of and predisposition to future diabetes mellitus type 216, and this aspect could be more relevant in females 
than in males. In addition, recent data also highlight a positive association between the atrial concentrations of 
ketogenic amino acids and hydroxybutyrate and persistent atrial fibrillation36. In contrast, in mice, C0 and a small 
set of 17 ACs have been found to be more elevated in females than in males37. The discrepancy could depend on 
the animal species (mouse versus rat). Moreover, the animal strain could have some importance. For example, in 
the heart of Wistar rats, carnitine and C6, C12, C14, C16, C18, C18:1; and C18:2 are lower in the male than in the 
female heart11, while C8, C16:1, C18:3; C20, C20:1; C20:2, C20:4, C22, C22:1, C22:4 and C22:6 were similar in 
both sexes. Here, we show that the reverse is observed in Sprague Dawley rats for C6, C12, C14, C16, C18, C18:1 
and C18:2. The discrepancy between Wistar and Sprague Dawley rats suggests the importance of strain for sex 
differences has already evidenced studying different parameters38,39.
Globally, each animal organ has a different metabolic profile that is influenced by sex in an organ- and 
parameter-specific way. The organ differences in carnitine and ACs probably reflect the different metabolic roles 
of each organ. Namely, cardiac mitochondria are specialized in ATP generation, primarily from fatty-acid oxida-
tion, and the urea cycle is very relevant in hepatic mitochondria, whereas renal mitochondria seem to rely on the 
metabolism of some amino acids40. The influence of sex on organ-specific differences in metabolism confirms the 
importance of sex in understanding physiology and disease, as already shown in studies that examine different 
parameters.
As already mentioned, differences in the metabolome among different organs have been already described in 
the brain, heart, kidney, and liver tissues of 26 mammalian species29,30. However, these studies do not consider 
the influence of sex, as males and females are not separately analysed. Globally, the higher concentration of car-
nitines and amino acids in males may, at least partially, depend on an organ size that it is bigger in males than 
in females37. However, this reasoning does not seem to hold true because sex differences are not evident for all 
studied compounds and for all organs. The observed sex differences could partially depend on sex hormones41,42.
Interestingly, in all organs of both sexes, a positive correlation exists between Met (a precursor of endogenous 
synthesis of C0) and C0, whereas Lys (another precursor of C0 endogenous synthesis) is not associated with C0, 
suggesting a more relevant role of Met in the endogenous synthesis of C0. Interestingly, the strength of the corre-
lations between Met and C0 depends on the sex and the organ. Val and Xle (both precursors of C5) are positively 
associated with C5 in all female organs, whereas in males, the correlation is present only in the liver and heart. 
Again, the strength of the correlations is organ-and sex-specific, as in the case of C3 and C4DC.
Sex Liver Heart Kidney
C0 – Met
M r = 0.835; P < 0.001 r = 0.718; P = 0.002 r = 0.837; P < 0.001
F r = 0.637; P < 0.001 r = 0.754; P < 0.001 r = 0.664; P = 0.006
M
C3 – Val
F r = 0.694; P < 0.001 r = 0.671; P = 0.006 r = −0.305; P = 0.279
M r = 0.667; P < 0.001 r = 0.139; P = 0.611 r = 0.375; P = 0.162
F
C3 – Xle
M r = 0.713; P < 0.001 r = 0.525; P = 0.043 r = −0.182; P = 0.521
F r = 0.663; P < 0.001 r = 0.307; P = 0.257 r = 0.475; P = 0.07
M
C5 – Val
F r = 0.817; P < 0.001 r = 0.804; P < 0.001 r = 0.108; P = 0.704
M r = 0.617; P = 0.001 r = 0.546; P = 0.03 r = 0.746; P < 0.001
F
C5 – Xle
M r = 0.854; P < 0.001 r = 0.625; P = 0.01 r = 0.103; P = 0.71
F r = 0.640; P < 0.001 r = 0.664; P = 0.006 r = 0.796; P < 0.001
M
C4DC – Val
F r = 0.834; P < 0.001 r = 0.389; P = 0.146 r = 0.556; P = 0.037
M r = 0.693; P = 0.001 r = 0.514; P = 0.05 r = 0.618; P = 0.013
F
C4DC – Xle
M r = 0.838; P < 0.001 r = 0.432; P = 0.104 r = 0.657; P = 0.001
F r = 0.698; P < 0.001 r = 0.654; P = 0.008 r = 0.536; P = 0.038
Table 1. Analysis of correlations among levels of carnitines and amino acids in male (M) and female (F) rat organs. 
The Spearman Product Moment Correlation coefficient (r) and the P value are reported for each tissue and sex.
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Cluster analysis identifies homogenous groups of observations only in the heart, clearly separating male from 
female animals, confirming univariate analysis. The variance among organs and sexes is mainly explained by 
PCA in that the first 2 components show a variance higher than 70% in each sex and in each organ. In particular, 
all variables contribute to Comp 1, whereas amino acids mainly contribute to Comp 2. LDA confirms the differ-
ences among organs being more effective in doing that than PCA, at least in our dataset but it is not effective in 
separating sexes.
The metabolic profiles seem to be specific to each tissue but males and females have a divergent sex-specific 
trajectory especially in the heart, suggesting that metabolomic analysis combined with multivariate analysis (clus-
ter analysis, LDA and PCA) are effective tools for differentiating sex-and tissue-specific differences in rat organs, 
as previously shown in humans43. In particular, cluster analysis seems to be the most suitable method to evidence 
sex differences, at least in our samples.
Figure 6. Cluster analysis depicting liver (A), heart (B) and kidney (C) sample distribution on the basis of 
Ward’s method used for hierarchical clustering. All dendrograms were constructed using together male and 
female samples per each organ metabolomic dataset. Male samples are depicted using a blue dot while female 
samples are in red.
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This appears especially true at cardiac level and this are in line with the numerous differences observed in car-
diovascular diseases11,12. Finally, these results provide a prospective resource for the study of pathophysiology and 
developing novel therapeutic targets in precision medicine. Knowledge of metabolomics can, in fact, help to identify 
biomarkers for disease and therapeutic efficacy and, as consequence, the determination and management of illness.
Figure 7. LDA score plot of all molecules (Panel A) and PCA of all molecules stratified according to sex and 
organ (panel B–F). Panel A, black and the red colours indicate male and female samples, respectively. Plotted 
ellipses estimate a region where 95% of population points are expected to fall. Panels B and C represent PCA 
loading plots in male and female liver samples; Panels D and E represent PCA loading plots in male and female 
heart samples; and Panels F and G represent PCA loading plots in male and female kidney samples.
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Methods
Animals. Male and female Sprague-Dawley rats (7 weeks old) were purchased from Harlan, Italy. Rats (2–3 
per cage; males separated from females) were maintained on a 12 h light/dark cycle and were allowed food 
and water ad libitum until being sacrificed. All animals received the same food (standard commercial pelleted 
diet), the same water and the same housing conditions (included an adaptation period of 2 weeks before exper-
iments). The experimental protocols were carried out in accordance with Italian law (DL 116, 1992) and the 
National Institutes of Health principles of laboratory animal care (NIH 80–33, revised 1996), and approved by the 
Independent Bioethics Committee for the Use of Experimental Animals at the University of Sassari (CIBASA). 
The sacrifice of the animals was performed in the morning for both sexes to avoid any variation due to time of 
sample collection. The animals were euthanized by decapitation, and the thoracic and abdominal cavities were 
opened to expose the hearts, livers and kidneys. The organs were rapidly removed and washed with ice-cold PBS. 
Parts of each tissue were weighed and homogenized in ice-cold PBS and stored at −80 °C.
Metabolite measurements. Metabolites were extracted according to procedures already used for human 
tissues44. The frozen tissues were homogenized in 500 μL of 50:50 cold methanol/0.1 M HCl. The mechanical 
homogenization was performed using Dounce homogenizer, coupled with loose pestle. Proteins were separated 
by metabolite by centrifugation at 13,000 rpm, 60 min, 4 °C. The protein pellet was dissolved in 7 M urea, 2 M 
thiourea, 30 mM Tris-HCl, and 4% CHAPS, and the protein content was determined by Lowry assay45. The super-
natant was collected and adjusted to pH 7–8 with KOH and re-centrifuged (40 min at 13,000 rpm). The super-
natant was collected, dried under nitrogen and used for the subsequent analysis of amino acids and ACs. The 
dried supernatant was dissolved in methanol containing labelled standards. The standard concentrations were 
in the 500–2500 μmol/L range for amino acids and in the 7.6–152 μmol/L range for ACs. Labelled amino acids 
were 15N, 2-13C-Gly, 2H4-Ala, 2H8-Val, 2H3-Leu, 2H3-Met, 13C6-Phe, 13C6-Tyr, 2H3-Asp, 2H3-Glu, 2H2-Orn, 2H2-Cit, 
and 2H4,5-13C-Ar. The labelled carnitines were 2H9-C0, 2H3-C2, 2H3-C3, 2H3-C4, 2H9-C5, 2H3-C8, 2H9-C14, and 
2H3-C16. After 20 min at room temperature on an orbital shaking system, the samples were dried under a nitro-
gen flow at 50 °C. The ACs and amino acids were derivatized to butyl esters with 80 μL of 3 N HCl in N-butanol at 
65 °C for 25 min. After derivatization, the samples were dried under nitrogen flow at 50 °C and then re-suspended 
in 300 μL of acetonitrile/water (70:30) containing 0.1% formic acid. Forty μL were injected in the flow injection 
analysis mode for the MS/MS experiments. The analyte panel consisted of 14 amino acids and 37 ACs.
The reported amino acids, with exception of Lys, and ACs were measured by LC-MS/MS as previously 
described46,47. The analysis was performed using an API 4000 triple quadrupole mass spectrometer (Applied 
Biosystems-Sciex, Toronto, Canada) coupled with an 1100 series Agilent high-performance liquid chromato-
graph (Agilent Technologies, Waldbronn, Germany). Data were quantitatively analysed with ChemoView v1.2 
software by comparing the analyte and its corresponding internal standard. The MS/MS analysis of Ala, Val, Xle, 
Met, Phe, Tyr, Asp, and Glu was performed by using a Neutral Loss of 102 Da scan function; the other amino acids 
(Orn, Cyt, Arg, ArgSucc) were analysed using a Multiple Reaction Monitoring (MRM) experiment. Finally, the 
AC analysis was performed by a Precursor Scan of 85 Da fragments.
The use of internal standardization employing stable isotope-labelled versions of the analytes allowed us to 
correct for the matrix effect. The accuracy and precision of the method are evaluated in each set of analyses using 
quality control (QC) samples prepared at four different concentrations (low, mid, high and very high). The quality 
control samples were provided by the Center for Disease Control and Prevention (Atlanta, GA, USA). Table S1 
shows the QC analytical information. Lys, which is directly linked to carnitine metabolism was measured by 
HPLC as previously described47,48 with an Agilent Technologies 1200 Series LC System with an Agilent Zorbax 
Eclipse XDB-C18 analytical column (5 μm, 4.6 × 150 mm) and Agilent Eclipse XDB-C18 analytical guard column 
(5 μm, 4.6 × 12.5 mm). The amino acid was identified and quantified by its retention time and absorption ratio 
by comparison with the ratio of authentic compounds in the calibration solution. Metabolomic data were nor-
malized by the tissue protein content. Quality controls were provided by ERNDIM (European Research Network 
for evaluation and improvement of screening, Diagnosis and treatment of Inherited disorders of Metabolism, 
Manchester, UK) (www.erndimqa.nl).
Statistical analysis. For the statistical analysis of the data, males and females were compared. Data are 
reported as the median ± median absolute deviation (MAD). The distribution of samples was evaluated using the 
Kolmogorov–Smirnov and Shapiro tests. Continuous parametric variables were analysed using Student’s t-test. 
Non-parametric variables were compared with the Mann-Whitney rank test. An intra-sex analysis of the data 
was performed by one-way ANOVA on the ranks. The strength of the association between pairs of variables was 
evaluated by the Spearman Product Moment Correlation coefficient using the SigmaStat software. For all tests, a 
P value ≤ 0.05 was considered statistically significant.
Cluster analysis, a method for identifying homogenous groups of objects called clusters, was performed using 
Ward’s method. Observations in a specific cluster share many characteristics, but they are very different to objects 
not belonging to that cluster. Ward’s method for hierarchical clustering, which uses the F value to maximize the 
significance of differences between cluster, obtaining the highest statistical power, was undertaken in order to 
determine the number of clusters, or subgroups, present in the data49.
LDA looks for linear combinations of independent variables by means of a qualitative dependent variable 
and several quantitative independent variables, and it is also referred to as chemometric in the literature50,51. 
The generated confusion matrix (Table S1), which allows visualization of the performance of an algorithm, con-
tains the reclassification of the observations (actual versus predicted) and allows to quickly see the percentage of 
well-classified observations (the ratio of the number of observations that have been well classified over the total 
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number of observations). In our dataset, the confusion matrix was equal to 97% confirming the suitability of this 
method for metabolomic data analysis (Table S2).
PCA is an unsupervised multivariate statistical tool that analyses data sets consisting of a large number of 
variables to develop a new and easier model with a smaller number of artificial analyses that accounts for most of 
the variance in the data set. Data were normalized and used for PCA analysis. Samples were compared for male 
and female organs, and in the case that one sample value was not available, it was treated with a mean normalized 
value imputation.
Cluster analysis, PCA and LDA were computed using the statistical package Statistica for Windows (ver. 5.1., 
1997) (Statsoft Inc., Tulsa, OK, USA).
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